Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

Renewal of Skin Epidermal Stem Cells

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Expression of secreted and membrane-bound mucins in the airways of piglets experimentally infected with Mycoplasma hyopneumoniae.

Veterinary journal (London, England : 1997)·2011

Same author

Malignant melanoma of the vulva: an extension of cutaneous melanoma?

Gynecologic oncology·2011

Same author

Molecular inflammation as an underlying mechanism of the aging process and age-related diseases.

Journal of dental research·2011

Same author

Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2.

Vaccine·2011

Same author

Target structure induced suppression of the ionization cross section for very low energy antiproton-hydrogen collisions.

Physical review letters·2011

Same author

Synthesis of cold antihydrogen in a cusp trap.

Physical review letters·2011

Same journal

Real-World Outcomes of Stapokibart-Based Combination Therapy for Bullous Pemphigoid: A Single-Center Retrospective Cohort.

Clinical and experimental dermatology·2026

Same journal

A second case of recessive mosaicism in ABCA12 causing a congenital unilateral epidermal nevus.

Clinical and experimental dermatology·2026

Same journal

Dermatopathology.

Clinical and experimental dermatology·2026

Same journal

Persistent Bilateral Palmar Hyperkeratotic Papules in an Adolescent Male.

Clinical and experimental dermatology·2026

Same journal

Shuddering Attacks in an Infant Treated with Atenolol for Infantile Hemangioma: A Previously Unreported Adverse Effect.

Clinical and experimental dermatology·2026

Same journal

Male genital fixed drug eruption: a systematic review.

Clinical and experimental dermatology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

Expression of RUNX3 in skin cancers.

J H Lee¹, J-K Pyon, D W Kim

¹Department of Plastic and Reconstructive Surgery, Hanyang University Guri Hospital, Guri, Korea.

Clinical and Experimental Dermatology

|June 1, 2011

Summary

This summary is machine-generated.

Runt-related transcription factor 3 (RUNX3) is overexpressed in skin cancers like melanoma and squamous cell carcinoma, suggesting it acts as an oncogene, not a tumor suppressor. Further research confirmed its nuclear localization and role in cell proliferation.

More Related Videos

Cell Population Analyses During Skin Carcinogenesis

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression

Published on: August 3, 2011

Related Experiment Videos

Last Updated: Jun 1, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

Cell Population Analyses During Skin Carcinogenesis

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression

Published on: August 3, 2011

Area of Science:

Oncology
Molecular Biology
Dermatology

Background:

Runt-related transcription factor 3 (RUNX3) expression is typically reduced in many cancers.
However, some studies indicate elevated RUNX3 in specific cancers, such as basal cell carcinoma (BCC).
This study investigates RUNX3's role in skin tumors, exploring its oncogenic or tumor-suppressive potential.

Purpose of the Study:

To examine RUNX3 expression patterns in normal skin versus various malignant skin tumors.
To determine if RUNX3 functions as an oncogene or a tumor suppressor in the context of skin carcinogenesis.

Main Methods:

Western blotting and immunohistochemistry were used to quantify RUNX3 expression in 24 and 48 skin specimens, respectively (including malignant melanoma, squamous cell carcinoma, BCC, and normal skin).
Subcellular localization of RUNX3 protein was analyzed in skin cancer tissues.
A cell proliferation assay using siRNA-mediated RUNX3 knockdown was performed on a melanoma cell line (G361).

Main Results:

RUNX3 was notably absent in normal skin but significantly overexpressed in all analyzed malignant melanoma (MM) and squamous cell carcinoma (SCC) samples.
Overexpression was also observed in most basal cell carcinoma (BCC) samples.
Immunohistochemistry confirmed RUNX3 overexpression across all analyzed skin cancer types, with nuclear localization observed.
Silencing RUNX3 in melanoma cells led to reduced proliferation.

Conclusions:

The findings indicate that RUNX3 possesses oncogenic properties in skin cancers.
RUNX3 does not function as a tumor suppressor in the context of these malignancies.
Its nuclear expression correlates with increased cell proliferation in skin tumors.